Gender dysphoria is a psychological condition where an individual experiences discomfort or distress due to a mismatch between their sex assigned at birth and their gender identity. This condition can lead to mental health issues such as depression, anxiety, low self-esteem, and social isolation. Gender-affirming care aims to support individuals in living authentically according to their gender identity, regardless of the sex they were assigned at birth. One significant aspect of gender-affirming care is hormone therapy, also known as hormone replacement therapy (HRT) or gender-affirming hormone therapy (GAHT).
Transgender Hormone Therapy: Transgender hormone therapy involves administering sex hormones and other hormonal medications to transgender or gender nonconforming individuals. The goal is to align their secondary sexual characteristics with their gender identity. There are two main types of hormone therapy based on the desired outcomes:
Masculinizing Hormone Therapy: This therapy is for transgender men or transmasculine individuals and involves the use of androgens (such as testosterone) and antiestrogens to promote male secondary sexual characteristics.
Feminizing Hormone Therapy: This therapy is for transgender women or transfeminine individuals and involves the use of estrogens, sometimes combined with antiandrogens, to promote female secondary sexual characteristics.
Safety and Monitoring:
Hormone therapy for transgender individuals is generally safe when administered under the supervision of a qualified medical professional. Regular monitoring through screenings and lab tests is essential to ensure safety and efficacy. These tests typically check blood count (hemoglobin), kidney and liver function, blood sugar, potassium, and cholesterol levels. It's important to follow the prescribed dosage, as taking more medication than directed can lead to health problems, including:
- Increased risk of cancer, Heart attack from blood thickening, Blood clots, Elevated cholesterol levels etc
